T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Clinical trials for T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis early-phase trial tests a new cell therapy for people with T-cell leukemia or lymphoma that has come back or not responded to treatment. Researchers take a patient's own T-cells, add a special receptor (CD7.CAR) to help them recognize and attack cancer cells, and give them b…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 09:09 UTC
-
New hope for tough T-Cell cancers: immunotherapy after transplant shows promise
Disease control Recruiting nowThis early-phase trial tests whether adding the immunotherapy drug daratumumab after a stem cell transplant is safe for children, teens, and young adults with high-risk T-cell acute lymphoblastic leukemia or lymphoma. About 30 participants will receive the drug after standard tra…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: New York Medical College • Aim: Disease control
Last updated May 17, 2026 09:09 UTC
-
Supercharged immune cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis early-phase study tests a new treatment for people with T-cell leukemia or lymphoma that has come back. The therapy uses the patient's own (or their donor's) immune cells, which are modified in the lab to better recognize and attack cancer cells. The goal is to see if this a…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 04, 2026 16:32 UTC